Eterna Therapeutics
ERNA
#10753
Rank
$7.06 M
Marketcap
$6.06
Share price
6.11%
Change (1 day)
206.06%
Change (1 year)

Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2025

Volume in USD (price x number of shares), data since 2025

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$1.53 M-52.81%
2025$3.25 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sanofi
SNY
$5.07 M$47.08 M๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
$22.28 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
$19.08 M$33.78 M๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.2 M$6.03 M๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/A$0 M๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
$5.5 M$81.63 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
$89.98 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA